SightMD, New York's leading multi-specialty ophthalmology practice, is thrilled to welcome two highly accomplished vitreoretinal specialists, Dr. Eric Sigler and Dr. Ketan Laud, to its team. The addition of Dr. Sigler and Dr. Laud underscores SightMD's commitment to delivering advanced retinal and vitreous care to communities across New York.
HAUPPAUGE, N.Y., Dec. 16, 2024 /PRNewswire-PRWeb/ -- SightMD, New York's leading multi-specialty ophthalmology practice, is thrilled to welcome two highly accomplished vitreoretinal specialists, Dr. Eric Sigler and Dr. Ketan Laud, to its team. The addition of Dr. Sigler and Dr. Laud underscores SightMD's commitment to delivering advanced retinal and vitreous care to communities across New York.
brings extensive experience and innovation in retinal and vitreous care to SightMD. He earned his Bachelor of Science in Biology from the State University of New York at Albany and his medical degree from the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed his ophthalmology residency at Yale University School of Medicine, where he was elected Chief Resident, further solidifying his leadership and expertise in the field.
Dr. Sigler has made significant contributions to the field of vitreoretinal surgery. He was the first surgeon in New York to implant the sustained-release port delivery system for macular degeneration during clinical trials and the first to utilize this advanced treatment after FDA approval. His work continues to shape the landscape of retinal care, as he actively participates in clinical research and publishes extensively on innovative techniques and discoveries in ophthalmology. Dr. Sigler will be seeing patients at SightMD's , , and locations.
"Joining SightMD allows me to continue offering patients the latest in retinal and vitreous care while remaining committed to personalized, compassionate treatment," said Dr. Sigler. "I am delighted to be part of the excellent team of doctors and staff at SightMD, and look forward to continuing to serve the community of Long Island and the New York area"
earned his medical degree and completed his ophthalmology residency at New York Medical College. He further refined his expertise through two prestigious fellowships in Retina/Vitreous Surgery at the University of British Columbia Faculty of Medicine and Columbia University/VRMNY, where he was mentored by renowned leaders in the field, Drs. Stanley Chang and Lawrence Yannuzzi.
With over a decade of experience, Dr. Laud is dedicated to serving patients both locally on Long Island and out of state. He provides an individualized treatment approach, collaborating closely with his patients to achieve optimal visual outcomes in a comfortable and welcoming environment.
Dr. Laud is passionate about offering the most innovative therapies to his patients. He regularly serves as a principal investigator for national clinical trials and has published numerous peer-reviewed scientific articles. This involvement allows his patients access to cutting-edge treatments and a higher level of expertise in their application.
As a faculty member in the Department of Ophthalmology at Mount Sinai Medical Center, Dr. Laud trains residents and fellows. He also serves as an educator and lecturer at regional, national, and international retinal meetings, sharing his insights on emerging therapies and research trials.
Recognized for his commitment to excellence, Dr. Laud has been honored annually as a Top Doctor by Castle Connolly and New York Magazine, and he has been featured in Newsday's Top Doctors. Dr Laud will be seeing will be seeing patients at SightMD's , and locations.
When asked what he is most looking forward to about joining SightMD, Dr. Laud stated, "I am excited to be joining the talented team at SightMD and to assist patients with their retinal care!"
The addition of Dr. Sigler and Dr. Laud will further enhance SightMD's reputation for providing cutting-edge retinal and vitreous care across New York. Both specialists prioritize patient-centered, minimally invasive approaches that prioritize early preventive treatment and innovative techniques. Their dedication to patient care and groundbreaking advancements in retinal surgery perfectly align with SightMD's mission to deliver exceptional eye care to every patient.
For more information or to schedule an appointment with Dr. Eric J. Sigler or Dr. Ketan Laud, please visit or call 855.295.4144.
SightMD is actively seeking ophthalmology professionals who are interested in joining its outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact the VP of Growth, Franc Galinanes, at (631) 396-8340 or [email protected]
About SightMD
SightMD is a rapidly-growing integrated ophthalmic group, offering patients access to over 80 doctors through the convenience of 40 locations across New York. SightMD's track record of providing clinically-excellent care spans over 50 years, and its services include LASIK laser vision correction, laser cataract surgery and lens implantation, oculoplastic surgery, general eye exams, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit
Media Contact
Stephanie Penza, SightGrowthPartners, 6318352613, [email protected],
SOURCE SightMD
Share this article